Antoman, Cristin A.
HRN: 24-69-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2024
METRONIDAZOLE 500MG (TAB)
03/20/2024
03/27/2024
IV
500mg
Q8hrs X 7 Days
S/P Primary CS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes